Clinical aspects of spatially fractionated radiation therapy treatments

• Published in: Physica medica Vol. 111; p. 102616
• Main Authors: Grams, Michael P., Deufel, Christopher L., Kavanaugh, James A., Corbin, Kimberly S., Ahmed, Safia K., Haddock, Michael G., Lester, Scott C., Ma, Daniel J., Petersen, Ivy A., Finley, Randi R., Lang, Karen G., Spreiter, Sheri S., Park, Sean S., Owen, Dawn
• Format: Journal Article
• Language: English
• Published: Italy Elsevier Ltd 01.07.2023
• Subjects: GRID; Lattice; Spatially fractionated; Spatially fractionated; Lattice; GRID
• ISSN: 1120-1797; 1724-191X
• DOI: 10.1016/j.ejmp.2023.102616

•Spatially fractionated radiation therapy (SFRT) can be a useful clinical modality for large or radioresistant tumors.•There is renewed interest in the clinical implementation of SFRT.•Dosimetric parameters associated with SFRT can be difficult to interpret without correlative outcomes data.•A successful SFRT program requires the multidisciplinary expertise and collaboration of physicians, physicists, dosimetrists, and radiation therapists. To provide clinical guidance for centers wishing to implement photon spatially fractionated radiation therapy (SFRT) treatments using either a brass grid or volumetric modulated arc therapy (VMAT) lattice approach. We describe in detail processes which have been developed over the course of a 3-year period during which our institution treated over 240 SFRT cases. The importance of patient selection, along with aspects of simulation, treatment planning, quality assurance, and treatment delivery are discussed. Illustrative examples involving clinical cases are shown, and we discuss safety implications relevant to the heterogeneous dose distributions. SFRT can be an effective modality for tumors which are otherwise challenging to manage with conventional radiation therapy techniques or for patients who have limited treatment options. However, SFRT has several aspects which differ drastically from conventional radiation therapy treatments. Therefore, the successful implementation of an SFRT treatment program requires the multidisciplinary expertise and collaboration of physicians, physicists, dosimetrists, and radiation therapists. We have described methods for patient selection, simulation, treatment planning, quality assurance and delivery of clinical SFRT treatments which were built upon our experience treating a large patient population with both a brass grid and VMAT lattice approach. Preclinical research and patient trials aimed at understanding the mechanism of action are needed to elucidate which patients may benefit most from SFRT, and ultimately expand its use.